Clinical Trial

Fecal Microbiota Transplantation (FMT) in Patients With Moderate to Severe Acute Pancreatitis

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a randomized, double-blind and placebo-controlled study. The purpose of this study is to evaluate the efficacy and safety of FMT in patients with moderate to severe acute pancreatitis.
Trial Details
NCT Number NCT07153809
Lead Sponsor Changhai Hospital
Conditions Acute Pancreatitis, Severe Acute Pancreatitis
Enrollment 80 participants
Start Date 2024-10-12
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-04